36 participants
A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-01
- Start Date:
- 2020-10-09
- Completion:
- 2025-04-21
Conditions
- Multiple Myeloma
Interventions
- DRUG